Generation of cytotoxic NK cells in peripheral blood and bone marrow of patients with acute myelogenous leukemia after continuous infusion with recombinant interleukin‐2

A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

1987 • 2,769 citations

Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer

1987 • 1,224 citations

The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.

1986 • 1,106 citations

Response of resting human peripheral blood natural killer cells to interleukin 2.

1984 • 616 citations

In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.

1985 • 600 citations

Lymphokine-activated killer cell activity

1987 • 235 citations

Induction of NK cell activity against fresh human leukemia in culture with interleukin 2.

1987 • 215 citations

Effectiveness and tolerability of low-dose cyclophosphamide and low-dose intravenous interleukin-2 in disseminated melanoma [corrected].

1988 • 200 citations

Phase I evaluation of recombinant interleukin-2 in patients with advanced malignant disease.

1986 • 144 citations

Influence of dose and duration of infusion of interleukin-2 on toxicity and immunomodulation.

1988 • 138 citations

Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens.

1989 • 85 citations

In vivo induction of the lymphokine-activated killer phenomenon: interleukin 2-dependent human non-major histocompatibility complex-restricted cytotoxicity generated in vivo during administration of human recombinant interleukin 2.

1988 • 82 citations

Generation of NK cell activity from human bone marrow.

1987 • 53 citations

Natural immunity cancer and biological response modification

1986 • 45 citations

Natural killer (NK) cell immunodeficiency in patients with chronic myelogenous leukemia

1987 • 37 citations

Reassessment of LAK phenomenology: a review.

1987 • 37 citations

Interleukin-2 and Killer Cells in Cancer

2018 • 31 citations

Current opinion in immunology

1989 • 30 citations

Analysis of effector mechanisms in cancer

1989 • 19 citations

Characterization of interleukin 2-expanded human peripheral blood lymphocytes: Not only NKH-1+-NK cells but also NKH-1+ and NKH-1− T cells are LAK effectors

1988 • 16 citations

Immunologic and clinical aspects of natural killer cells in human leukemia.

1990 • 10 citations

Heterogeneity of Cell Populations from Human Peripheral Blood Mediating Lymphokine-Stimulated Cytotoxicity

2015 • 7 citations

Antileukemia Reactivity of Endogenous and Interleukin-2-Activated Natural Killer Cells

2015 • 5 citations